Learning Platform
Глоссарий Troubleshooting Темы Колода
Урок 03.07 · 10 мин
Продвинутый
Clinical EnglishEBMDiagnostic reasoningHealth policyUS healthcare system

Health and medicine — C2

By B2 you owned everyday health vocabulary and the basic specialties. At C1 you added clinical-encounter vocabulary, common diagnostics, and the rough shape of the US system. At C2 you cross into the discourse where clinical reasoning, evidence-based medicine, and US health policy are taken apart in detail. You can read a New England Journal of Medicine perspective piece, a JAMA editorial on a major trial, a Kaiser Health News investigation of surprise billing, an Atlantic feature on healthcare disparities, and a Health Affairs policy paper on Medicare Advantage — without translation drag and without missing the technical or political subtext.

The vocabulary in this lesson sits at the intersection of clinical medicine, biostatistics, health-services research, and US healthcare policy. It is the working language of physicians, medical residents, public-health professionals, health-policy analysts at Kaiser Family Foundation and the Commonwealth Fund, and senior health-care journalists. Much of it is American-specific — the donut hole, prior authorization, step therapy, DRGs, the Stark Law — and these terms have no neat European equivalent.

A pragmatic note: medical language is asymmetric. Doctors use cancer-of-the-X shorthand in conversation but carcinoma of the X in writing; they say the patient clinically and they personally; they say MI (heart attack) and AKI (kidney injury) routinely. Knowing the registers — clinical talk, journal English, patient-facing language, medical-press style — is core C2 competence.

Health and medicine — advanced (C1)

Clinical reasoning — how doctors think

  • history / the history / HPI (history of present illness) — the patient’s story
  • PMH (past medical history) / PSH (past surgical history) / FH (family history) / SH (social history)
  • ROS (review of systems) — systematic symptom inventory
  • the physical / the physical exam / PE — examination
  • vitals / vital signs — temperature, BP, HR, RR, SpO₂
  • chief complaint (CC) — the patient’s stated reason for visit
  • presenting problem / the presentation
  • acuity — how sick (the ED triages by acuity: ESI 1-5)
  • the differential / differential diagnosis / the DDx — list of possible diagnoses
  • leading diagnosis / most likely diagnosis / the working diagnosis
  • rule out / r/o — exclude a possibility
  • rule in — confirm
  • pre-test probability — likelihood of disease before testing
  • post-test probability — likelihood after testing, updated by Bayes’ theorem
  • clinical pearls / the gestalt — accumulated heuristic wisdom
  • a zebra vs a horse — rare diagnosis vs common (when you hear hoofbeats, think horses, not zebras)
  • the workup — the planned set of investigations
  • the disposition / the disposition decision (D/C, admit, transfer)
  • AMA — against medical advice (leaving discharge without recommendation)
  • the read / the wet read — the radiologist’s interpretation (formal vs preliminary)

Disease vocabulary at the right register

  • etiology — the cause(s) of a disease
  • pathophysiology / pathophys — mechanism of disease
  • pathogenesis — process by which disease develops
  • idiopathic — of unknown cause
  • iatrogenic — caused by medical intervention
  • nosocomial / hospital-acquired
  • prognosis — expected course and outcome
  • morbidity vs mortality — sickness vs death
  • all-cause mortality vs cause-specific mortality
  • case fatality rate vs infection fatality rate
  • the natural history of a disease — its course without intervention
  • comorbidity / multimorbidity — co-existing conditions
  • acute vs subacute vs chronic vs recurrent
  • insidious onset vs acute onset vs abrupt onset
  • paroxysmal — sudden, episodic
  • refractory — not responding to treatment
  • intractable — resistant to relief
  • palliative — symptom-focused, not curative
  • the palliative-curative axis / goals of care
  • end-of-life care / hospice
  • DNR / DNI (Do Not Resuscitate / Intubate) / POLST (Physician Orders for Life-Sustaining Treatment)
  • advance directive / living will / healthcare proxy
NOTE

Etiology, pathophysiology, and pathogenesis are sometimes used loosely but technically distinguish: etiology = the cause (e.g., Helicobacter pylori is the etiology of most peptic ulcers); pathophysiology = the abnormal functioning the disease produces (acid hypersecretion, mucosal disruption); pathogenesis = the developmental sequence from cause to manifest disease. A C2 medical reader catches when authors conflate them.

Diagnostic test characteristics — Bayes for clinicians

This is one of the most consequential vocabulary clusters at C2. Most clinicians use it loosely; the well-trained ones use it precisely, and the gap is visible in any medical discussion.

  • sensitivity — among diseased, the fraction the test correctly identifies (true-positive rate)
  • specificity — among non-diseased, the fraction the test correctly rules out (true-negative rate)
  • PPV (positive predictive value) — among test-positives, the fraction who actually have the disease
  • NPV (negative predictive value) — among test-negatives, the fraction who actually don’t
  • prevalence — how common the disease is in the population
  • the prevalence dependence of PPV/NPV — PPV/NPV depend on prevalence; sensitivity/specificity (mostly) don’t
  • likelihood ratio (LR+, LR−) — multiplies pre-test odds to give post-test odds
  • ROC curve (Receiver Operating Characteristic) — sensitivity vs (1 − specificity) across thresholds
  • AUC / AUROC (Area Under the Receiver Operating Characteristic curve)
  • calibration vs discrimination — predictions match observed rates vs distinguish cases
  • the Bayes factor

Trial vocabulary

  • RCT (randomized controlled trial) / double-blind RCT — see also the methodology section in the science lesson
  • phase I / II / III / IV trials — safety/dose finding / efficacy / pivotal / post-marketing
  • adaptive trial — pre-specified modifications based on interim data
  • basket trial vs umbrella trial — one drug across many tumor types vs many drugs for one cancer with different biomarkers
  • platform trial — ongoing infrastructure for multiple comparisons (e.g., RECOVERY, REMAP-CAP)
  • endpoint — pre-specified outcome
  • primary endpoint vs secondary endpoint
  • composite endpoint — combined outcome (death OR hospitalization OR …)
  • MACE (Major Adverse Cardiovascular Events) — a common composite
  • surrogate endpoint — measurable proxy for clinical outcome (LDL for cardiovascular disease)
  • hard endpoint vs soft endpoint — death/MI/stroke vs symptom scales
  • clinically meaningful difference vs statistically significant difference
  • minimal clinically important difference (MCID)
  • NNT (number needed to treat) — patients you must treat to prevent one event
  • NNH (number needed to harm) — patients you must treat to cause one harm
  • absolute risk reduction (ARR) vs relative risk reduction (RRR) — RRR sounds bigger and is more often quoted by industry
  • hazard ratio (HR) — time-to-event analog of relative risk
  • odds ratio (OR) — case-control standard
  • intention-to-treat (ITT) vs per-protocol vs as-treated analyses
  • modified intention-to-treat (mITT)
  • non-inferiority margin — the worst acceptable difference vs comparator
  • futility — pre-specified threshold for stopping early due to lack of effect
  • DSMB (Data and Safety Monitoring Board) — independent oversight committee

Evidence-based medicine

  • EBM (evidence-based medicine) — practice based on best available evidence
  • the EBM hierarchy / evidence pyramid — see science lesson; in medicine: RCT > cohort > case-control > case series > expert opinion
  • clinical guidelines / practice guidelines
  • the GRADE framework — rates evidence quality and recommendation strength
  • strong recommendation vs conditional recommendation vs weak recommendation
  • shared decision-making (SDM) — clinician and patient deciding together
  • patient preferences / values clarification
  • medical paternalism vs patient autonomy
  • informed consent — patient understanding of risks, benefits, alternatives
  • the four pillars of medical ethics — autonomy, beneficence, non-maleficence, justice
  • futility (ethically) — treatment unlikely to provide meaningful benefit
  • medical overuse / low-value care / Choosing Wisely campaign
  • deprescribing — stopping medications no longer beneficial
  • polypharmacy — multiple concurrent medications
  • medication reconciliation (med-rec)
  • drug interactions / drug-drug interactions (DDIs)
  • the Beers list / the START/STOPP criteria — geriatric prescribing tools
  • adherence vs compliance — preferred newer term vs older paternalistic one
  • medication persistence — staying on a medication over time

Specialty vocabulary at C2 — a sampler

  • cardiology: ACS (acute coronary syndrome), STEMI vs NSTEMI, troponin elevation, ejection fraction (EF), HFrEF/HFpEF (heart failure with reduced/preserved EF), AFib (atrial fibrillation), CAD (coronary artery disease), valvular disease, TAVR (transcatheter aortic valve replacement), the heart team
  • oncology: solid tumor vs hematologic malignancy, staging (TNM, AJCC), grading, immunotherapy (PD-1/PD-L1 inhibitors, checkpoint inhibitors), CAR-T (chimeric antigen receptor T-cell therapy), tumor microenvironment, ctDNA (circulating tumor DNA) / liquid biopsy, MRD (minimal residual disease)
  • neurology: stroke (ischemic vs hemorrhagic), tPA / tenecteplase, thrombectomy, TIA, dementia (Alzheimer’s, vascular, Lewy body, frontotemporal), Parkinson’s, MS, epilepsy, seizure semiology
  • gastroenterology: GERD, IBD (Crohn’s vs UC), IBS, NAFLD (now MASLD), MASH (formerly NASH), cirrhosis, HCC
  • pulmonology: COPD (emphysema and chronic bronchitis), asthma, ILD (interstitial lung disease), IPF, OSA (obstructive sleep apnea), pulmonary hypertension
  • endocrinology: T1DM vs T2DM, GLP-1 receptor agonists (semaglutide, tirzepatide), HbA1c, MODY, hypothyroidism, hyperthyroidism, adrenal insufficiency
  • infectious disease: sepsis (and the Sepsis-3 definition), septic shock, antimicrobial stewardship, MDR/XDR organisms (multi-drug-resistant / extensively-drug-resistant), the One Health approach
  • mental health: MDD (major depressive disorder), bipolar I/II, OCD, PTSD, complex PTSD (C-PTSD), generalized anxiety disorder (GAD), schizophrenia spectrum, the DSM-5(-TR), the ICD-11
  • rheumatology: RA, lupus (SLE), psoriatic arthritis, ankylosing spondylitis, the biologics (TNF inhibitors, JAK inhibitors)
  • nephrology: AKI (acute kidney injury), CKD (chronic kidney disease) staging, ESRD, dialysis (hemodialysis vs peritoneal), kidney transplant
TIP

Recent terminology shift: fatty liver disease has been renamed in stages — NAFLD (non-alcoholic fatty liver disease) was replaced in 2023 by MASLD (metabolic-dysfunction-associated steatotic liver disease), and NASH by MASH. The change reflects emphasis on metabolic etiology over the non-alcoholic framing. C2 readers should know both old and new terms.

US healthcare system — the specifically American architecture

  • the ACA (Affordable Care Act / Obamacare, 2010) — the major US health reform
  • the marketplace / the exchange / healthcare.gov — ACA-mandated insurance shopping
  • premium tax credit / APTC (Advance Premium Tax Credit) — ACA subsidies
  • cost-sharing reduction (CSR) — additional subsidies for low-income enrollees
  • the individual mandate — penalty for not having insurance (zeroed federally in 2017, state mandates remain in some states)
  • Medicaid expansion — ACA-funded state expansion to adults under 138% FPL
  • the Medicaid coverage gap — non-expansion-state low-income adults too poor for marketplace subsidies, too rich for traditional Medicaid
  • dual eligible — enrolled in both Medicare and Medicaid
  • CHIP (Children’s Health Insurance Program)

Insurance vocabulary

  • premium — monthly payment
  • deductible — annual amount paid out of pocket before insurance pays
  • coinsurance — percentage of costs after deductible (e.g., 20%)
  • copay / copayment — fixed amount per visit (e.g., $30)
  • out-of-pocket maximum (OOP max) — annual ceiling on patient spending
  • HDHP (high-deductible health plan) — usually paired with HSA
  • HSA (Health Savings Account) — pre-tax savings for medical expenses
  • FSA (Flexible Spending Account)
  • HRA (Health Reimbursement Arrangement)
  • PPO vs HMO vs EPO vs POS — plan types
  • in-network vs out-of-network
  • narrow network / ultra-narrow network — limited provider lists for cheaper plans
  • balance billing / surprise billing — provider billing patient for the gap between billed and insurance-paid amounts (largely banned for emergencies by the No Surprises Act, 2022)
  • prior authorization / preauthorization / preauth / PA — insurance approval required before service
  • step therapy / fail first — insurance requires cheaper drug to fail before approving expensive one
  • formulary — list of covered drugs
  • tier — formulary stratification by patient cost
  • rebate — manufacturer payment to PBM
  • PBM (Pharmacy Benefit Manager) — intermediary between insurers, pharmacies, and manufacturers
  • GPO (Group Purchasing Organization)
  • the donut hole / the Medicare Part D coverage gap — partly closed by ACA, fully closed by IRA
  • CMS (Centers for Medicare and Medicaid Services)
  • Medicare Parts A, B, C, D — hospital, outpatient, Advantage, drug
  • Medicare Advantage (MA) — privately administered Medicare; controversial for upcoding
  • risk adjustment — payment adjustment for patient acuity
  • upcoding — billing for higher complexity than warranted
  • Star Ratings — CMS quality scoring for MA plans

Payment and delivery

  • fee-for-service (FFS) — payment per service rendered
  • value-based care (VBC) — payment tied to outcomes
  • capitation — fixed payment per patient per period
  • bundled payment — single payment for an episode
  • ACO (Accountable Care Organization) — provider group accepting shared risk
  • MSSP (Medicare Shared Savings Program)
  • the triple aim — better care, better health, lower cost (Berwick); sometimes extended to quadruple aim (with clinician well-being) or quintuple aim (with equity)
  • DRG (Diagnosis-Related Group) — Medicare inpatient payment classification
  • RVU (Relative Value Unit) — Medicare physician payment unit
  • the conversion factor — RVU-to-dollars
  • the Sustainable Growth Rate (SGR) — defunct Medicare physician-payment formula
  • MACRA / MIPS / APMs — post-SGR payment frameworks
  • CON (Certificate of Need) laws — state regulation of new facilities
  • the Stark Law / the Anti-Kickback Statute (AKS) — physician self-referral and kickback regulation
  • EMTALA (Emergency Medical Treatment and Labor Act) — emergency stabilization mandate
  • HIPAA (Health Insurance Portability and Accountability Act) — privacy regulation
  • PHI (Protected Health Information)

Healthcare disparities — vocabulary at C2

  • healthcare disparities / health disparities / health inequities
  • social determinants of health (SDOH) — non-medical drivers
  • structural racism in health
  • the Black-white maternal mortality gap — major US disparity
  • redlining and health — historical residential segregation effects
  • ZIP-code destiny — health outcomes vary sharply by neighborhood
  • food desert / food swamp — limited healthy food access
  • medical mistrust — partly justified by historical abuses (Tuskegee, Henrietta Lacks)
  • implicit bias in clinical decisions
  • race-based eGFR adjustment — abandoned in 2021 as racial-essentialist
  • community health workers (CHWs) / promotoras
  • federally qualified health centers (FQHCs) — safety-net primary care
  • safety-net hospital — primary serves uninsured/Medicaid
  • the 340B program — drug discount for safety-net providers

EHR/EMR — the documentation regime

  • EHR (electronic health record) / EMR (electronic medical record) — terms used loosely; EHR is technically broader
  • Epic / Cerner (Oracle Health) — the dominant US EHRs
  • the chart / the note
  • SOAP note — Subjective, Objective, Assessment, Plan
  • the H&P (history and physical) — admission note
  • progress note / daily note
  • the consult note
  • the discharge summary
  • CC (chief complaint) / HPI / PMH / PSH / FH / SH / ROS / PE / A/P (assessment and plan)
  • note bloat — bloated notes from copy-forward and template overuse
  • upcoding through documentation — documenting more elements to justify higher E/M code
  • E/M codes (Evaluation and Management) — CPT codes for cognitive work
  • ICD-10 (and the coming ICD-11) — diagnosis codes
  • CPT — procedure codes
  • interoperability — data exchange across systems
  • the Cures Act — 21st Century Cures Act with information-blocking provisions
  • open notes / patient-portal release — patients seeing their notes (now mandatory)
  • clinical decision support (CDS) — EHR-embedded alerts
  • alert fatigue — clinicians ignoring excessive alerts

AmE-specific vs international vocabulary

USInternational / UKNote
ER / emergency department / EDA&E (Accident & Emergency)the ER (older) and ED (modern preferred)
attendingconsultantsenior physician
residentregistrar (UK)trainee physician
internfirst-year resident / FY1 (UK)PGY1 in US
fellow(varies)sub-specialty trainee
nurse practitioner (NP) / PAadvanced clinical practitionermid-level providers
primary care provider (PCP)GP (general practitioner)UK is GP, US is PCP
Tylenolparacetamolacetaminophen (US generic) vs paracetamol (international)
epinephrineadrenalinesame drug, different names
labor and deliverylabour ward / maternityobstetrics-specific
HMO / PPO(no NHS equivalent)US insurance types
copay(no NHS equivalent)US patient cost-sharing
WARNING

Acetaminophen (US generic) and paracetamol (international) are the same drug; Tylenol is the US brand. Confusion between this and other US-vs-international drug-name pairs (epinephrine/adrenaline, albuterol/salbutamol, lidocaine/lignocaine) is a common source of clinical and translation errors. C2 medical readers should know both names of major drugs.

Collocations

  • present with symptoms, complaints, findings
  • rule out / rule in a diagnosis
  • work up a patient
  • admit to the floor, the ICU, the step-down
  • discharge home, to a facility, to hospice
  • transition to comfort care, palliation
  • start / hold / titrate / wean / taper a medication
  • dose / dose-adjust / dose-reduce / dose-escalate
  • prescribe / order / write for / refill / authorize
  • order labs / draw labs / send labs
  • image / scan / x-ray / cross-section / contrast
  • biopsy / sample / cultivate / culture
  • resuscitate / code / call a code / run the code
  • intubate / extubate / ventilate / oxygenate
  • suspect / consider / favor / lean toward / lean away from a diagnosis
  • achieve / fail to achieve / meet the primary endpoint
  • enroll / consent / randomize / blind / unblind

Phrases and locutions

  • the prudent layperson standard — emergency-care entitlement test
  • the patient is in extremis — gravely ill
  • circling the drain — clinical deterioration (informal)
  • status post / s/p — after (s/p MI = after heart attack)
  • comfort measures only (CMO)
  • goals-of-care conversation
  • futile but not unethical treatment
  • the empty-suit consult — courtesy consult expected to say what was already planned
  • the curbside consult — informal opinion
  • the medical-legal exposure
  • defensive medicine
  • the standard of care
  • the eyeball test — clinical gestalt
  • looking sick / looking well
  • a soft call vs a hard call
  • above my pay grade — out of one’s scope
  • the patient is failing to progress
  • the patient is medically optimized — ready for discharge from acute care
  • non-actionable findings — incidentalomas not requiring action
Проверка знанийKnowledge check
In a JAMA editorial you read: 'The trial showed a 24% relative risk reduction in MACE with an NNT of 142 over five years; the primary endpoint was driven by the soft component, the hard endpoints showed no signal, and the manufacturer-friendly intention-to-treat analysis was reported above the more skeptical per-protocol numbers. CMS may still approve, but the prior-authorization burden will discipline real-world uptake.' What is the editorial signalling about the trial and its likely real-world impact?
ОтветAnswer
The editorial is conveying significant skepticism despite a headline-positive result. The tells: (1) *24% RRR* sounds impressive, but *NNT of 142* (treat 142 patients for five years to prevent one event) reveals modest absolute benefit — the editorialist is implicitly contrasting how RRR overstates compared to absolute risk reduction or NNT; (2) *primary endpoint driven by the soft component* — composite endpoints (MACE typically combines death, MI, stroke, hospitalization) can show positive results from the least-meaningful component (e.g., hospitalization rather than death); (3) *hard endpoints showed no signal* — mortality and major events didn't improve, which is the most important real-world fact; (4) *manufacturer-friendly intention-to-treat* — ITT typically dilutes toward the null but here helped the drug, suggesting it benefited from non-protocol-completers being counted; (5) *per-protocol numbers* — the more skeptical analysis was reported less prominently; (6) *prior-authorization burden will discipline uptake* — even if CMS approves coverage, payers will require PA, which in practice limits use to the highest-risk patients and reduces real-world prescription rates. The cumulative meaning: positive trial, soft signal, dressed up by analytic choices, with payer mechanics likely to limit real-world penetration regardless of approval status. The C2 reader catches the editorial's restrained but evident doubt.

Common Russian-speaker mistakes

  1. Inflammation / inflammatory used loosely*. In English clinical context inflammation is the specific physiological process (heat, redness, swelling, pain, loss of function — calor, rubor, tumor, dolor, functio laesa); inflammatory disease has a specific meaning. For general swelling use edema (medical) or swelling; for irritation use irritation or redness. Russian воспаление maps to both inflammation and broader irritation; in medical English be specific.
  2. Insult meaning stroke. Extreme false friend with Russian инсульт. In English insult is verbal abuse or, in medical jargon, a biological injury (a neurological insult), but not the everyday word for stroke. For the cerebrovascular event use stroke (the everyday medical term), CVA (cerebrovascular accident — slightly outdated), ischemic stroke / hemorrhagic stroke (typed). He had an insult in everyday AmE means he was offended.
  3. Infarct as everyday word*. AmE infarct is technical (myocardial infarct); the everyday word is heart attack (myocardial infarction) or stroke (cerebral infarction). He had an infarct in lay context will be incomprehensible; he had a heart attack is the everyday phrasing.
  4. Operation loosely*. AmE distinguishes operation (the surgical procedure) from procedure (broader; includes diagnostic and minor) and intervention (any clinical action). For minor things use procedure (colonoscopy is a procedure, not an operation); for major surgery use surgery or operation (open-heart surgery, hip-replacement surgery).
  5. Polyclinic / clinic for outpatient department. Russian поликлиника doesn’t map cleanly. AmE clinic is a general outpatient facility; a doctor’s office / the practice / the office is what an individual physician operates from. Polyclinic is rarely used in AmE; it sounds Soviet. The hospital outpatient department might be the outpatient clinic or the ambulatory care center.
  6. Pharmacy / drugstore distinction*. AmE pharmacy is the prescription-dispensing function; drugstore is the retail store (CVS, Walgreens) that contains a pharmacy. I’m going to the pharmacy and I’m going to the drugstore are largely interchangeable in AmE everyday speech; I’m going to the apothecary is archaic.
  7. Therapy loosely for treatment in everyday speech. In AmE medical context therapy is broad (drug therapy, radiation therapy, physical therapy, psychotherapy); treatment is even broader (any clinical action toward improvement); regimen is a specific schedule. Russian терапия maps to all of these; in AmE pick the right one. Cancer doctors say the patient is on chemotherapy or on systemic therapy; psychiatrists say the patient is in therapy; primary-care doctors say let’s start treatment for hypertension.

Summary

  • Clinical reasoning vocabulary covers the history-physical-workup-disposition sequence, the differential diagnosis, pre/post-test probability, and the clinical gestalt.
  • Disease vocabulary distinguishes etiology, pathophysiology, and pathogenesis; comorbidity, multimorbidity, acuity, and natural history shape the language of severity and course.
  • Diagnostic test characteristics (sensitivity, specificity, PPV, NPV, likelihood ratios, ROC/AUC, calibration vs discrimination) underpin Bayesian clinical reasoning.
  • Trial vocabulary spans phases, endpoints (primary/secondary/composite/hard/soft/surrogate), NNT/NNH, ARR vs RRR, hazard ratios, and ITT vs per-protocol.
  • EBM hierarchy, GRADE, shared decision-making, and the Choosing Wisely / deprescribing agenda define modern evidence-based practice.
  • US-specific system vocabulary includes the ACA architecture, Medicare Parts/Advantage/star ratings, insurance plumbing (premium/deductible/coinsurance/PA/step therapy), payment models (FFS/VBC/capitation/bundled/ACO/MSSP), and the regulatory layer (Stark, AKS, EMTALA, HIPAA, the 340B program).
  • Disparities vocabulary covers SDOH, structural racism in health, ZIP-code destiny, food deserts, medical mistrust, and the safety-net architecture.
  • Russian false friends: insult for stroke, inflammation used loosely, infarct as everyday word, polyclinic for clinic, operation for any procedure, therapy for any treatment.

Next theme: Arts and culture — C2 — aesthetic, ekphrasis, mimesis, the sublime, kitsch, camp, postmodernism, hyperreality, the gaze, ideology critique.

Закончили урок?

Отметьте его как пройденный, чтобы отслеживать свой прогресс

Войдите чтобы оценить урок

Прогресс модуля
0 из 22